Swiss pharmaceutical group Novartis (NYSE:NVS) announced on Friday that it has reached an agreement to acquire ...

By Marleen Kaesebier and Bhanvi Satija March 27 (Reuters) - Swiss drugmaker Novartis will buy California-based biotech ...

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...

March 27 () - Swiss drugmaker Novartis said on Friday it will buy California-based biotech ‌company Excellergy in a deal ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company' or 'Jyong Biotech'), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...

Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for oncology needsAI-driven ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding ...

Gladstone Institutes’ 105,000-square-foot lease is one of the largest such deals in the city so far this year.

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

A California-based biotech company announced it will be cutting roughly half of its workforce after a disappointing study ...